Search for Clinical Trial Results

Hemophilia A - 31 Studies Found
Status | Study |
Completed |
Study Name: Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery Condition: Hemophilia A Date: 2006-07-25 Interventions:
|
Completed |
Study Name: Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery Condition: Hemophilia A Date: 2005-10-20 Interventions: Biological: ReFacto AF |
Recruiting |
Study Name: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Condition: Hemophilia A Date: 2016-07-26 Interventions: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u |
Completed |
Study Name: Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A Condition: Hemophilia A Date: 2012-03-22 Interventions: Drug: GreenGene Dose : 10 ~ 50IU/kg Administration method : intravenous infusion or bolus |
Enrolling by invitation |
Study Name: Platelet Function in Patients With Hemophilia A Condition: Hemophilia A Date: 2014-03-19 |
Completed |
Study Name: Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 Condition: Hemophilia A Date: 2005-09-08 Interventions: Drug: Antihemophilic factor, recombinant, manufactured protein-free |
Completed |
Study Name: Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients Condition: Hemophilia A Date: 2005-09-09 Interventions: Biological: Recombinant Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM) |
Completed |
Study Name: Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A Condition: Severe Haemophilia A Date: 2016-02-18 Interventions: Drug: Pharmacokinetic based dosage change Pharmacokinetic based dosing of factor VIII prophylaxis treatm |
Completed |
Study Name: Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients Condition: Hemophilia A Date: 2005-09-08 Interventions: Drug: Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment) |
Completed |
Study Name: Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A Condition: Hemophilia A Date: 2005-09-08 Interventions: Drug: Antihemophilic factor, recombinant, manufactured protein-free |